1-4 of 4 results for subject:Quinine
Librarians' tools
- Search time
- 0.25 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Quinine
- We searched for
- subject_t:Quinine
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health, what discussions his Department has had with clinical bodies on the potential connection between quinine and heart risk.
To ask the Secretary of State for Health, what discussions his Department has had with clinical bodies on the potential connection between quinine and heart risk.
The Medicines and Healthcare products Regulatory Agency (MHRA) continuously monitors the safety of all medicines on the market in the United Kingdom and seeks independent expert advice from the Commission on Human Medicines on important new safety issues.
Quinine can be an effective medicine for the treatment and prevention of severe nocturnal leg cramps in adults. Quinine is also used to treat malaria. Quinine tablets are only available on prescription from a doctor.
It has been known for many years that quinine can affect the electrical activity of the heart, particularly in high doses or when it is given in combination with other medicines affecting the heart or to patients with existing heart problems.
A recently completed routine periodic review of quinine considered two recent studies that reported a small increased risk of death in patients taking quinine for leg cramps or restless legs syndrome. Although the studies were associated with limitations, the product information (including patient information leaflet) is currently being updated to contain additional warnings to support informed decision-making between healthcare professionals and their patients. The updated information will also be communicated to healthcare professionals in November.
SI 2003/2647 (Negative instrument). Coming into force in accordance with regulation 1 (2)
SI 2003/2647 (Negative instrument). Coming into force in accordance with regulation 1 (2)
To ask the Secretary of State for Health, if he will make a statement on his position towards Directive 2002/67/EC (OJ L191, vol 45, 19th July 2002) on the labelling of foodstuffs containing (a) quinine and (b) caffeine; how many products on sale in the UK will be affected; and...
To ask the Secretary of State for Health, if he will make a statement on his position towards Directive 2002/67/EC (OJ L191, vol 45, 19th July 2002) on the labelling of foodstuffs containing (a) quinine and (b) caffeine; how many products on sale in the UK will be affected; and...